Immunologic mediators of outcome for irradiated oropharyngeal carcinoma based on human papillomavirus status. Meshman J, Velez MA, Wang PC, Abemayor E, et al. Oral Oncol 2019;89:121-126.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Meshman J, Velez MA, Wang PC, Abemayor E, et al. Immunologic mediators of outcome for irradiated oropharyngeal carcinoma based on human papillomavirus status. Oral Oncol 2019;89:121-126.
PMID: 30732949